ArticlePsychopharmacology2026
Heroin-induced neuroadaptations of CB1 receptors and their involvement in conditioned place preference.
Article in Psychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
rationaleChronic opioid use leads to long-term dysregulation of the systems related to reward, pain and stress. In recent years, much attention has been given to the role of endocannabinoid CB1 receptors in opioid-driven behaviors. However, neuroadaptations of these receptors following opioid exposure is less clear.
objectivesIn this study, we systematically assessed CB1 receptor protein expression within the cortico-mesolimbic-basal ganglia circuit in rats with a history of heroin exposure and assessed the involvement of CB1 receptors in heroin conditioned place preference (CPP).
results(1) During naloxone-precipitated withdrawal, heroin-treated rats showed significantly more withdrawal signs including rapid weight loss, wet dog shakes, abnormal posture, genital grooming and urination than saline control rats. Although heroin-treated rats scored higher on criteria pertaining to vocalization, defecation, jumping and profuse salivation than did saline-treated rats, these trends did not reach statistical significance. (2) Using Western Blotting, we found that there were significant decreases in CB1 receptor protein expression in the nucleus accumbens (NAc), hypothalamus (Hypoth), substantia nigra (SN) and pedunculopontine nucleus (PPT), but no changes in this protein were detected in the prefrontal cortex, insula, dorsal striatum, medial/lateral septi, amygdala, dorsal hippocampus, ventral tegmental area and lateral tegmental nucleus. 3). Intracranial microinjections of AM251 (a CB1 receptor antagonist) into the NAc, SN, Hypoth or PPT caused significant and dose-dependent reductions in heroin CPP.
conclusionsThese data suggest that CB1 receptors undergo region-specific neuroadaptation following chronic heroin exposure and are involved in heroin CPP.
Indexed as
Identifiers
41569414What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.